Pfizer rises after annual profit forecast raise

3SBio

05/08/2025 12:08

** Shares of drugmaker Pfizer PFE.N rise about 3.7% to $24.39 premarket

** Raises FY adjusted EPS guidance by 10c at midpoint to $2.90-$3.10 range

** Q2 adjusted EPS of 78c beats estimate of 58c - data compiled by LSEG

** New guidance absorbs almost 20c one-time hit from licensing deal with China's 3SBio 1530.HK

** Analysts, on average, expect 2025 profit of $3.02 per share - data compiled by LSEG

** Stock down 11% YTD

 (Reporting by Sriparna Roy in Bengaluru)

 ((Sriparna.Roy@thomsonreuters.com;))